News

SfRBM's Senior Awards Committee has announced that the recipient of the 2018 Lifetime Achievement Award is Daret St. Clair, Ph.D., of the University of Kentucky, for her seminal work on the role of manganese superoxide dismutase (MnSOD) in cancer development and therapy. 

A recent breakthrough by Dr. Thomas Michel of Harvard School of Medicine has shown that insulin impacts the body in a unique way. The study, recently published in FRBM, unveiled an entirely unexpected mechanism whereby insulin-dependent generation of hydrogen peroxide (H2O2) in cardiac myocytes controls heart contractility and critical cell signaling pathways. These research findings have direct implications for our understanding of diabetic cardiomyopathy, which is a major cause of morbidity and mortality for patients with diabetes.

This special issue contains a collection of state-of-the art review articles and an updated overview of HNE involvement in human pathophysiology.  It will be a valuable resource for researchers in the field, graduate and post-graduate students as well as grant awarding agencies.  The issue is dedicated to the discovery of HNE and leading scientist Hermann Esterbauer on the occasion of the 20th anniversary of his death.

Dr. Chris Kevil has been named as the new Co-Editor in Chief of Redox Biology, replacing Dr. Victor Darley-Usmar who stepped down after 5 years of leading the editorial team.

SFRBM's Senior Awards Committee has announced that the recipient of the 2017 Discovery Award is Gregg Semenza, Ph.D. of Johns Hopkins University School of Medicine.  Dr. Semenza was recognized for his discovery of hypoxia-inducible factor (HIF-1a) transformed the redox field.

Approximately 2.9 million people in the US suffer from epilepsy, according to the CDC. For patients living with this diagnosis and their doctors it is often difficult to predict the onset or progression of chronic seizures. Thanks to a newly published study from Drs. Manisha Patel and Li-Ping Liang of the University of Colorado, that may be changing.

SFRBM is partnering with the American Physiological Society (APS) to host a symposium on "Redox Biology: A Unifying Theme in the Etiology of Human Diseases" at the 2018 Experimental Biology meeting in San Diego.

SFRBM's Senior Awards Committee has announced that the recipient of the 2016 Lifetime Achievement Award is Henry Jay Forman, Ph.D. of the University of Southern California.

The Society for Free Radical Biology and Medicine is now the Society for Redox Biology and Medicine (SFRBM).

A new patent has been issued for a method that uses the SOD-mimetic agent TEMPOL to treat fibrocystic disease of the breast (FD).